11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Join Veristat and ACER Therapeutics at the VEDS Scientific Meeting Day 2022
ACER Therapeutics Decentralized Study Design: A Phase 3 Clinical Study in Patients with COL3A1-Positive Vascular Ehlers-Danlos Syndrome to Determine Whether Celiprolol Delays the Onset of VEDS-related Clinical Events abstract has been accepted to the poster session.
The one-day in-person meeting will be held on Monday, August 29, 2022, from 8:00am – 5:00 pm in Paris, France, as part of The Marfan Foundation’s Science in Paris meeting. Follow the conference link (below) to learn more.
Conference Details
Website: https://thevedsmovement.org/
2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...